KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Goodwill & Intangibles (2016 - 2019)

Arbutus Biopharma (ABUS) has disclosed Goodwill & Intangibles for 5 consecutive years, with $66.3 million as the latest value for Q2 2019.

  • Quarterly Goodwill & Intangibles fell 18.26% to $66.3 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $66.3 million through Jun 2019, down 18.26% year-over-year, with the annual reading at $66.3 million for FY2018, 20.12% down from the prior year.
  • Goodwill & Intangibles hit $66.3 million in Q2 2019 for Arbutus Biopharma, roughly flat from $66.3 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $546.1 million in Q2 2015 to a low of $66.3 million in Q3 2018.
  • Historically, Goodwill & Intangibles has averaged $242.1 million across 5 years, with a median of $123.8 million in 2016.
  • Biggest YoY gain for Goodwill & Intangibles was 5.57% in 2016; the steepest drop was 75.97% in 2016.
  • Year by year, Goodwill & Intangibles stood at $515.2 million in 2015, then crashed by 75.97% to $123.8 million in 2016, then tumbled by 32.95% to $83.0 million in 2017, then dropped by 20.12% to $66.3 million in 2018, then changed by 0.0% to $66.3 million in 2019.
  • Business Quant data shows Goodwill & Intangibles for ABUS at $66.3 million in Q2 2019, $66.3 million in Q1 2019, and $66.3 million in Q4 2018.